Full access
Brief Reports
Published Online: 15 January 2015

Evolution of General Practitioners’ Preferences for Antipsychotics in France, 2003–2010

Adeline Gallini, Pharm.D., Ph.D., Virginie Gardette, M.D., Ph.D., Naïma Oumouhou, M.Sc., Sandrine Andrieu, M.D., Ph.D., and Julie M. Donohue, Ph.D.Authors Info & Affiliations
Publication: Psychiatric Services
Volume 66, Number 4
https://doi.org/10.1176/appi.ps.201400020
Track CitationsAdd to favorites
PDF/EPUBFormats

Abstract

Objective:

The study examined changes in French general practitioners’ (GPs) antipsychotic preferences between 2003 and 2010, a period when evidence challenging the superiority and safety of second-generation antipsychotics was introduced.

Methods:

Data from the IMS Health Disease Analyzer database for a cohort of 347 GPs (with 12 or more antipsychotic prescriptions in 2003 and in 2010) were used. For each year and GP, preferred antipsychotic was defined as the drug most frequently prescribed at the patient level. Trends in mean number of prescriptions, preferred drug, and changes in preferred antipsychotic class were documented.

Results:

The mean annual number of antipsychotic prescriptions increased over the period (p<.001). The percentage of GPs who preferred a second-generation antipsychotic tripled, from 16% in 2003 to 50% in 2010. In 2010, 42% of GPs who preferred first-generation antipsychotics in 2003 had switched their preference to second-generation antipsychotics.

Conclusions:

GPs’ preferences for antipsychotics changed dramatically between 2003 and 2010.

Formats available

You can view the full content in the following formats:

View PDF/EPUBView Full Text

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services

Cover: Breakfast in the Garden, by Frederick Carl Frieseke, circa 1911. Oil on canvas, 26 x 325/16 inches. Daniel J. Terra Collection, 1987.21. Terra Foundation for American Art, Chicago/Art Resource, New York City.

Psychiatric Services
Volume 66 • Number 4 • April 01, 2015
Pages: 434 - 437
PubMed: 25588416

History

Received: 17 January 2014
Revision received: 24 June 2014
Accepted: 21 August 2014
Published online: 15 January 2015
Published in print: April 01, 2015

Authors

Details

Adeline Gallini, Pharm.D., Ph.D.
Except for Dr. Donohue, the authors are with the Department of Epidemiology, University of Toulouse, Toulouse, France, and with INSERM UMR 1027, Toulouse (e-mail: [email protected]). Dr. Donohue is with the Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.
View all articles by this author
Virginie Gardette, M.D., Ph.D.
Except for Dr. Donohue, the authors are with the Department of Epidemiology, University of Toulouse, Toulouse, France, and with INSERM UMR 1027, Toulouse (e-mail: [email protected]). Dr. Donohue is with the Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.
View all articles by this author
Naïma Oumouhou, M.Sc.
Except for Dr. Donohue, the authors are with the Department of Epidemiology, University of Toulouse, Toulouse, France, and with INSERM UMR 1027, Toulouse (e-mail: [email protected]). Dr. Donohue is with the Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.
View all articles by this author
Sandrine Andrieu, M.D., Ph.D.
Except for Dr. Donohue, the authors are with the Department of Epidemiology, University of Toulouse, Toulouse, France, and with INSERM UMR 1027, Toulouse (e-mail: [email protected]). Dr. Donohue is with the Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.
View all articles by this author
Julie M. Donohue, Ph.D.
Except for Dr. Donohue, the authors are with the Department of Epidemiology, University of Toulouse, Toulouse, France, and with INSERM UMR 1027, Toulouse (e-mail: [email protected]). Dr. Donohue is with the Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.
View all articles by this author

Competing Interests

Dr. Andrieu has received consulting fees, payment for lectures, or institution grant support from Beaufour Ipsen Pharma SAS, Chiesi, Elan, Eli Lilly and Company, Esai Inc., Exhonit, Janssen, Lundbeck Inc., Nestle S.A., Novartis, Pfizer, Pierre Fabre Laboratories, Roche, Sanofi, and Servier. The other authors report no financial relationships with commercial interests.

Funding Information

This research was supported by an unconditional grant from the Direction de la Recherche, des Études, de l’Évaluation et des Statistiques (DREES), Ministry for Health, France. Access to data from IMS Health Disease Analyzer was authorized under a contract with DREES within France’s Ministry for Health. The funding organization had no role in the design or conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard
Tips for downloading citations

View Options

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Item saved, go to cart
Purchase Options

Purchase this article to access the full text.

PPV Articles - Psychiatric Services

PPV Articles - Psychiatric Services

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share

×

As described within the American Psychiatric Association (APA)'s Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences. Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.